Match!
Gioacchino Tedeschi
Seconda Università degli Studi di Napoli
NeurosciencePhysical therapyMigraineMultiple sclerosisMedicine
306Publications
47H-index
7,951Citations
What is this?
Publications 315
Newest
#1Alfredo BerardelliH-Index: 73
#2Vincenzo SilaniH-Index: 57
Last. Cristina TassorelliH-Index: 38
view all 11 authors...
Source
#1Carlo FerrareseH-Index: 28
#2Vincenzo SilaniH-Index: 57
Last. Gioacchino TedeschiH-Index: 47
view all 8 authors...
Neurological manifestations of COVID-19 have been described in both single case reports and retrospective scanty case series. They may be linked to the potential neurotropism of the SARS-COV-2 virus, as previously demonstrated for other coronaviruses. We report here the description of a multicenter retrospective-prospective observational study promoted by the Italian Society of Neurology (SIN), involving the Italian Neurological Departments, who will consecutively recruit patients with neurologi...
Source
#1Francesco BrigoH-Index: 23
#2Simona BonavitaH-Index: 14
Last. Luigi LavorgnaH-Index: 13
view all 5 authors...
Source
#1Raffaele Dubbioso (University of Naples Federico II)H-Index: 11
#2Eduardo Nobile-Orazio (University of Milan)H-Index: 49
Last. Gian Maria Fabrizi (University of Verona)H-Index: 25
view all 9 authors...
Source
#1Marcello SilvestroH-Index: 4
Last. Antonio RussoH-Index: 71
view all 5 authors...
BACKGROUND: Monoclonal antibodies (mABs) against calcitonin gene-related peptide (CGRP) or its receptor have emerged as effective and well-tolerated preventive medications for migraine. The key role played by CGRP has been recently demonstrated also in the pathophysiology of cluster headache (CH), paving the way for studies aimed to investigate the effectiveness of mABs targeting CGRP also in CH. However, no trials have been conducted so far to test the efficacy and tolerability of erenumab as C...
Source
#1Simona BonavitaH-Index: 14
#2Gioacchino TedeschiH-Index: 47
Last. Luigi LavorgnaH-Index: 13
view all 4 authors...
We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quickly identify people with high risk of COVID-19 infection. This tool will also limit unnecessary accesses to the MS centers reducing the risk of spreading the infection.
Source
#1Marcello SilvestroH-Index: 4
Last. Antonio RussoH-Index: 71
view all 4 authors...
Source
#1Dario RicciardiH-Index: 1
#2Vincenzo TodiscoH-Index: 2
Last. Giovanni CirilloH-Index: 16
view all 5 authors...
Besides the prominent motor syndrome, some patients affected by amyotrophic lateral sclerosis (ALS) complain of many non-motor symptoms during the disease course, in particular chronic pain that significantly reduces the patients’ quality of life. Complex regional pain syndrome (CRPS) is a rare painful condition, rarely described in ALS patients. We present the clinical case of a patient affected by spinal-onset ALS, who developed a type I CRPS (CRPS-I) at the upper limbs. To the best of our kno...
Source
#1Federica GarramoneH-Index: 4
#2Chiara BaianoH-Index: 5
Last. Gabriella SantangeloH-Index: 30
view all 7 authors...
Background Despite the clinical importance of psychological factors in migraine, the relationship between personality traits, depression, and migraine has been poorly investigated.
Source
#1Francesca TrojsiH-Index: 16
#2Federica Di NardoH-Index: 4
Last. Sabrina EspositoH-Index: 15
view all 15 authors...
OBJECTIVE.: Advanced neuroimaging techniques may offer the potential to monitor disease progression in amyotrophic lateral sclerosis (ALS), a neurodegenerative, multisystem disease that still lacks therapeutic outcome measures. We aim to investigate longitudinal functional and structural magnetic resonance imaging (MRI) changes in a cohort of patients with ALS monitored for one year after diagnosis. METHODS.: Resting state functional MRI, diffusion tensor imaging (DTI), and voxel-based morphomet...
Source
12345678910